Edwards Lifesciences Corp

EWNYSE • USD
85.15 USD
↘ 0.04 (0.05%)AT CLOSE (03:59 PM EDT)
85.55
↗ 0.40 (0.47%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
85.55
↗ 0.40 (0.47%)
🔴Market: CLOSED

Edwards Lifesciences Corp (EW) trades at $85.15 per share. Technicals currently rate "Sell" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Oct 2, 2026.

Open?$85.52
High?$86.48
Low?$84.66
Prev. Close?$85.19
Volume?2.4M
Avg. Volume?3.2M
VWAP?$85.55
Rel. Volume?0.75x
Bid / Ask
Bid?$84.70 × 300
Ask?$87.47 × 200
Spread?$2.77
Midpoint?$86.09
Valuation & Ratios
Market Cap?49.1B
Shares Out?575.8M
Float?571.0M
Float %?99.2%
P/E Ratio?48.84
P/B Ratio?4.62
EPS?$1.74
Dividend?0.00%
Ex-Dividend?N/A
RelatedAMNHSIC
News
Profile
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
Employees
16.0K
Market Cap
49.1B
Industry
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Listed
2000-04-03
Address
ONE EDWARDS WAY
IRVINE, CA 92614
Phone: (949) 250-2500
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
100
Momentum?
31
Short Sent.?
78
Piotroski F-Score?3/9Weak
Altman Z-Score?12.14Safe
Confidence?60%Moderate
Full Fundamental Analysis →
Short InterestModerate
Short % of Float?1.59%Low
Short Interest?9.1M
Days to Cover?3.2
Free Float571.0M
Avg Daily Volume2.9M
Settlement Date2026-09-15
Financial Health
Current Ratio?4.52Strong
Quick Ratio?3.77Strong
Cash Ratio?1.93Strong
Debt/Equity?0.06Low
ValuationRICHLY VALUEDvs 2 peers + S&P 500
Score
44/100
P/E?
Peers
33
S&P
13
48.8PRICEY▾
P/B?
Peers
33
S&P
39
4.62FAIR▾
P/S?
Peers
33
S&P
15
7.54HIGH▾
P/FCF?
Peers
33
S&P
23
34.2FAIR▾
EV/EBITDA?
Peers
33
S&P
18
23.6HIGH▾
EV/Sales?
Peers
33
S&P
19
7.18HIGH▾
Returns & Efficiency
ROE?
Peers
33
S&P
32
9.5%FAIR▾
ROA?
Peers
100
S&P
61
7.2%STRONG▾
Cash Flow & Enterprise
FCF?$1.4B
Enterprise Value?$46.8B
Fundamentals ratios updated end of day